Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nigel J Pyne

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Seminars in Cell & Developmental Biology|May 6, 2004
The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transductionCatherine Waters, Susan Pyne, Nigel J Pyne
Advances in Experimental Medicine and Biology|March 11, 2010
Cyclic AMP signaling in pancreatic isletsBrian Furman, Wee Kiat Ong, Nigel J Pyne
Trends in Biochemical Sciences|March 30, 2016
Sphingosine Kinases: Emerging Structure-Function InsightsDavid R Adams, Susan Pyne, Nigel J Pyne
British Journal of Pharmacology|December 6, 2002
Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertensionFiona Murray, Margaret R MacLean, Nigel J Pyne
British Journal of Pharmacology|April 25, 2003
An assessment of the role of the inhibitory gamma subunit of the retinal cyclic GMP phosphodiesterase and its effect on the p42/p44 mitogen-activated protein kinase pathway in animal and cellular models of pulmonary hypertensionFiona Murray, Margaret R MacLean, Nigel J Pyne
The Biochemical Journal|January 25, 2008
Lipid phosphate phosphatases form homo- and hetero-oligomers: catalytic competency, subcellular distribution and functionJaclyn S Long, Nigel J Pyne, Susan Pyne
Cellular Signalling|October 9, 2020
Structure-function analysis of lipid substrates and inhibitors of sphingosine kinasesDavid R Adams, Susan Pyne, Nigel J Pyne
Handbook of Experimental Pharmacology|February 21, 2018
Sphingosine Kinases as Druggable TargetsSusan Pyne, David R Adams, Nigel J Pyne
Progress in Lipid Research|March 13, 2016
Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advancesSusan Pyne, David R Adams, Nigel J Pyne
Trends in Pharmacological Sciences|June 14, 2017
Sphingosine Kinase 2 in Autoimmune/Inflammatory Disease and the Development of Sphingosine Kinase 2 InhibitorsNigel J Pyne, David R Adams, Susan Pyne
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Seminars in Cell & Developmental Biology|May 6, 2004
The role of G-protein coupled receptors and associated proteins in receptor tyrosine kinase signal transductionCatherine Waters, Susan Pyne, Nigel J Pyne
Advances in Experimental Medicine and Biology|March 11, 2010
Cyclic AMP signaling in pancreatic isletsBrian Furman, Wee Kiat Ong, Nigel J Pyne
Trends in Biochemical Sciences|March 30, 2016
Sphingosine Kinases: Emerging Structure-Function InsightsDavid R Adams, Susan Pyne, Nigel J Pyne
British Journal of Pharmacology|December 6, 2002
Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertensionFiona Murray, Margaret R MacLean, Nigel J Pyne
British Journal of Pharmacology|April 25, 2003
An assessment of the role of the inhibitory gamma subunit of the retinal cyclic GMP phosphodiesterase and its effect on the p42/p44 mitogen-activated protein kinase pathway in animal and cellular models of pulmonary hypertensionFiona Murray, Margaret R MacLean, Nigel J Pyne
The Biochemical Journal|January 25, 2008
Lipid phosphate phosphatases form homo- and hetero-oligomers: catalytic competency, subcellular distribution and functionJaclyn S Long, Nigel J Pyne, Susan Pyne
Cellular Signalling|October 9, 2020
Structure-function analysis of lipid substrates and inhibitors of sphingosine kinasesDavid R Adams, Susan Pyne, Nigel J Pyne
Handbook of Experimental Pharmacology|February 21, 2018
Sphingosine Kinases as Druggable TargetsSusan Pyne, David R Adams, Nigel J Pyne
Progress in Lipid Research|March 13, 2016
Sphingosine 1-phosphate and sphingosine kinases in health and disease: Recent advancesSusan Pyne, David R Adams, Nigel J Pyne
Trends in Pharmacological Sciences|June 14, 2017
Sphingosine Kinase 2 in Autoimmune/Inflammatory Disease and the Development of Sphingosine Kinase 2 InhibitorsNigel J Pyne, David R Adams, Susan Pyne
Pageof 11